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ABSTRACT
Purpose: This study aimed to assess whether computed tomography (CT) findings can be used to predict
blood flow from the superior mesenteric artery (SMA) to the celiac artery (CA) region in patients with
median arcuate ligament syndrome (MALS).
Materials and methods: Two radiologists who reviewed 1,290 conventional SMA angiograms and CT scans
identified 36 patients with MALS. MALS was classified by their blood flow angiography findings as type A
(CA region not or barely visualized) and type B (CA region clearly visualized). The association between
patient age, sex, post-stenotic dilatation ratio of the celiac axis, maximum diameter of the pancreaticoduode-
nal arcade (PDA), and MALS classification based on SMA angiography was assessed.
Results: Of 36 MALS patients, 17 had MALS type A and 19 had MALS type B. The mean of the maximum
diameter of the PDA in MALS type A was 1.6 ± 0.9 mm (SD) and 4.3 ± 1.3 mm in MALS type B. The post-
stenotic dilatation ratio of the celiac axis was 2.4 ± 1.2 in MALS type A and 2.2 ± 1.4 in MALS type B. Only
maximum diameter of the PDA was a predictor of MALS type B (odds ratio, 15.7; 95% confidence interval,
2.3–108.1).
Conclusion: The maximum diameter of the PDA on CT angiography can be used to predict the blood flow
from the SMA to the CA region in patients with MALS.
Key words: pancreaticoduodenal arcade aneurysms, median arcuate ligament syndrome, MALS, CT
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INTRODUCTION
The median arcuate ligament (MAL) is a fibrous arch
that unites the diaphragmatic crura on either side of the
aortic hiatus. In 10–24% of humans, the ligament is
located low and compresses the proximal portion of the
celiac axis5). In a small subset of these patients, the
median arcuate ligament can compress the proximal cel-
iac axis enough to be hemodynamically significant and
cause symptoms. This phenomenon, known as median
arcuate ligament syndrome (MALS), may elicit symp-
toms due to ischemia1–3).
The rupture of a pancreaticoduodenal arcade (PDA)
aneurysm, one of the most critical complications related
to MALS, carries a mortality rate of 20–30%4–9). Com-
pression of the celiac axis can increase retrograde blood
flow from the superior mesenteric artery (SMA) to the
region of the celiac artery (CA) via pancreaticoduodenal
arterial collaterals. This may increase the flow in these
small-caliber vessels, resulting in local arterial hyperten-
sion leading to focal arterial wall thickening and true
aneurysm formation4,5,10–12). Consequently, assessing the
blood flow from the SMA to the CA region via pancreati-
coduodenal arterial collaterals is important for predict-
ing PDA aneurysms.
Although MALS is traditionally diagnosed using cathe-
ter angiography, non-invasive multidetector computed
tomography (MDCT) is an alternative diagnostic tool1,2,13)
that reportedly detected 1–4% of MALS cases among
patients who underwent MDCT2,13,14). However, blood
flow direction and degree cannot be assessed using tradi-
tional catheter angiography or Doppler ultrasonography.
We tested our hypothesis that the diameter of the celiac
axis or the PDA on computed tomography angiograms
(CTAs) can predict the blood flow from the SMA to the
CA region.
MATERIALS AND METHODS
This retrospective study was approved by our institu-
tional review board, which waived the need for informed
patient consent.
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Subjects
Between 2014 and 2016, 1,290 patients underwent
both conventional SMA angiography and computed
tomography (CT) studies at our institution. The interval
between SMA angiography and CT was no longer than 6
months. Two board-certified radiologists with 8 and 7
years of experience with abdominal radiology consensu-
ally reviewed the SMA angiographic and CT images.
MALS, defined as the characteristic focal narrowing of
the proximal celiac axis resulting in a hooked appearance
on three-dimensional (3D) CTAs5) , was diagnosed in 36
patients (29 men, seven women; median age, 69 years;
range, 47–90 years). Their imaging studies diagnosed
liver tumour in 12 patients, were performed before
transcatheter arterial chemoembolization (TACE) for
hepatocellular carcinoma (HCC) in 21, were performed
before transcatheter arterial embolization for PDA
aneurysm in two, and were used to obtain a preoperative
diagnosis for pancreatic cancer in one.
Conventional SMA angiography
A 4F shepherd hook catheter was placed into the SMA
and 20–25 mL of contrast medium was injected at a flow
rate of 4–5 mL/sec using an automatic injector (Dual
Shot; Nemoto Kyorindo; Tokyou, Japan). Angiograms
were acquired during expiration at 3 frames/sec.
Computed tomography
All CT scans were obtained on a 320- (Aquilion One;
Toshiba Medical Systems, Otawara, Japan), 256- (Revo-
lution; GE, Milwaukee, WI, USA), or 64-detector-row
(Light Speed VCT; GE, Milwaukee, WI, USA) CT scanner
during inspiration. The scanning parameters were:
(Aquilion One scanner) rotation time of 0.50 sec, beam
collimation 0.5 × 80 mm, section thickness and intervals
of 5.0 mm, helical pitch (beam pitch) of 0.813, table
movement of 65.0 mm/sec, scanning field-of-view (FOV)
of 50 cm, voltage of 120 kV, auto mA (noise index 10);
(Revolution scanner) rotation time of 0. 275 sec, beam
collimation of 0.625 × 64 mm, section thickness and
intervals of 5.0 mm, helical pitch (beam pitch) of 0.938,
table movement of 75.0 mm/sec, FOV of 50 cm, voltage
of 120 kV, auto mA (noise index 10); (Light Speed VCT)
rotation time of 0.45 sec, beam collimation 0.625 × 64
mm, section thickness and intervals of 5.0 mm, helical
pitch (beam pitch) of 0.938, table movement of 93.8
mm/sec, FOV of 50 cm, voltage of 120 kV, auto mA
(noise index 10).
The contrast medium dose in all patients was 600
mgI/kg body weight. The contrast medium was injected
into the cubital vein for 30 sec through a 22-G intrave-
nous catheter using an automatic injector. The scan tim-
ing for the arterial phase was determined with a bolus
tracking system; axial-, coronal-, and sagittal-section
images were reconstructed at a 1-mm slice thickness.
Image analysis
The two radiologists consensually classified MALS in
terms of blood flow from the SMA to the CA region on
SMA angiograms (type A: CA region not or barely visual-
ized [Figures 1a, b]; type B: CA region clearly visualized
[Figure 2]). They then measured the minimum and max-
imum diameter of the celiac axis and the maximum
diameter of the PDA on axial-, sagittal-, and coronal-
section CT angiograms. The diameter of the anterior or
posterior superior pancreaticoduodenal artery, the infe-
rior pancreaticoduodenal artery, and the dorsal pancre-
atic artery was calculated to obtain PDA data. The largest
was adopted as the maximum diameter of the PDA. The
post-stenotic dilatation ratio of the celiac axis was calcu-
lated with the formula: maximum/minimum diameter of
the celiac axis.
Fig. 1a
Fig. 1b
Figure 1 a. A 68-year-old man with hepatocellular carcino-
ma (HCC) underwent conventional angiography of the supe-
rior mesenteric artery (SMA) prior to transcatheter arterial
chemoembolization (TACE). The celiac artery (CA) region
was not visualized on the SMA angiogram. The diagnosis was
median arcuate ligament syndrome (MALS) type A. 
b. An 86-year-old man with hepatocellular carcinoma under-
went conventional angiography of the SMA before TACE. The
CA region was barely visualized on the SMA angiogram (ar-
row). The diagnosis was MALS type A.
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Statistical analysis
Statistically significant differences were identified
using the two-sided Student’s t test. A univariate logistic
regression analysis was also used to assess the associa-
tion between patient age and sex, post-stenotic dilatation
ratio of the celiac axis, and maximum diameter of the
PDA (independent variables) and MALS type on SMA
angiograms (outcome variables). We adopted a univari-
ate rather than multivariate analysis because the number
of patients was small.
A receiver operating characteristic curve (ROC) analy-
sis was used to calculate the most appropriate cut-off
value for the best predictor to obtain a threshold for pre-
dicting the blood flow from the SMA to the CA region on
SMA angiograms. The statistical analysis was performed
using statistical software (MedCalc v16.4; MedCalc
BVBA, Belgium). Differences of p < 0.05 were considered
statistically significant.
RESULTS
Based on SMA angiography findings, of the 36
patients, 17 had MALS type A and 19 had MALS type B.
The mean of the maximum diameter of the PDA in
MALS type A was 1.6 ± 0.9 mm (SD), while that of MALS
Figure 2 A 65-year-old man with hepatocellular carcinoma.
Conventional angiography of the superior mesenteric artery
was performed before transcatheter arterial chemoemboliza-
tion. The celiac artery region was clearly visualized (arrow).
The diagnosis was median arcuate ligament syndrome type B.
type B was 4.3 ± 1.3 mm. The mean diameter of PDA in
MALS type A was significantly smaller than that in
MALS type B (p < 0.01). The minimum and maximum
dilatation ratio of the celiac axis was 3.2 ± 1.1 mm and
6.8 ± 1.7 mm in MALS type A and 2.7 ± 1.0 mm and 5.4
± 2.4 mm in MALS type B. The post-stenotic dilatation
ratio of the celiac axis was 2.4 ± 1.2 in MALS type A and
2.2 ± 1.4 in MALS type B. There was no significant dif-
ferences between types A and B (p = 0.62).
In the univariate logistic regression analysis, only the
maximum diameter of the PDA was a variable predictor
of MALS type B (odds ratio [OR], 15.7; 95% confidence
interval [CI], 2.3–108.1; p < 0.01]; neither patient age or
sex nor post-stenotic dilatation ratio was a predictor of
MALS type B (Table 1).
ROC analysis of the relationship between maximum
diameter of the PDA and blood flow type from the SMA
to the CA region showed that the area under the ROC
curve was 0.97 (p < 0.01), while the threshold for the
maximum diameter of the PDA for predicting blood flow
type from the SMA to the CA region was 3 mm. The sen-
sitivity and specificity of this threshold were 100% and
88.2%, respectively.
Of the 36 patients, three had clinical significance for
MALS: two suffered rupture of a PDA aneurysm (Figures
3a–c) and the other required revascularization of the cel-
iac axis during pancreaticoduodenectomy for pancreatic
cancer. These three patients had MALS type B.
DISCUSSION
Our findings show that the maximum diameter of the
PDA on CTAs can predict blood flow from the SMA to
the CA region in MALS. Because PDA aneurysms are
thought to be attributable to increased retrograde blood
flow via the PDA4,5,10–12), patients with MALS type B may
be at high risk for PDA aneurysms. Both patients with
ruptured PDA aneurysms in the current study had MALS
type B. Thus, the maximum diameter of the PDA may be
useful stratifying the risk for PDA aneurysms.
Ours is the first report to describe the prediction of
blood flow in patients with MALS based on CTAs. MDCT
appears to be the most appropriate modality for diagnos-
ing MALS because it is relatively non-invasive and facili-
tates visualization via an optimal viewing angle1,2,13).
However, as most MALS cases diagnosed by CT are
asymptomatic and may not be clinically significant, an
assessment that addresses the blood flow in patients with
Table 1 Univariate logistic regression analysis of MALS type based on SMA angiogram findings.
Variable Type A (n = 17) Type B (n = 19) Odds ratio* P value
Mean age 74.7 ± 8.1 (SD) 68.7 ± 9.8 0.9 (0.9, 1.0) 0.06
Sex 3.5 (0.6, 21.4) 0.17
M 12 17
F 5 2
Mean maximum PDA diameter (mm) 1.6 ± 0.9 4.4 ± 1.3 15.7 (2.3, 108.1) < 0.01
Mean post-stenotic dilatation ratio 2.4 ± 1.2 2.2 ± 1.4 0.9 (0.5, 1.5) 0.62
Numbers in parentheses are 95% confidence intervals.
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Fig.3a
Fig.3b
Fig.3c
Figure 3 a. A 64-year-old man with abdominal pain and low
blood pressure underwent axial computed tomography (CT)
that showed a haemorrhage around the pancreas and extrava-
sation from a pancreaticoduodenal arcade (PDA) aneurysm.
b. Sagittal CT image revealing a hooked appearance (arrow).
The post-stenotic dilatation ratio of the celiac axis was 1.5. c.
Conventional superior mesenteric artery angiogram clearly
demonstrating the celiac artery region. The diagnosis was me-
dian arcuate ligament syndrome type B. The PDA aneurysm
(arrow) was treated with transcatheter arterial embolization.
MALS is necessary. Horton et al.1) reported that MALS
with post-stenotic dilation or collateral vessels may war-
rant clinical correlation; however, the blood flow in
patients with MALS has not been compared on CT and
conventional angiography. We found that the threshold
for the maximum diameter of the PDA for predicting the
degree of blood flow from the SMA to the CA region was
3 mm. Our observations may help assess the necessity
for intervention or constant follow-up in individuals with
MALS.
The post-stenotic dilatation ratio of the celiac axis was
not a predictor of MALS type B. Although post-stenotic
dilation of the celiac axis is often seen in MALS, it may
not be useful for predicting the development of a PDA
aneurysm. Collateral pathways, including the inferior
phrenic artery, an aberrant left hepatic artery, and intra-
hepatic communicating branches, deliver blood to the
celiac artery region15). Consequently, retrograde blood
flow in the PDA might not be increased in MALS with
post-stenotic dilation of the celiac axis but without dila-
tion of the PDA when collateral pathways not involving
PDA provided sufficient blood flow to the celiac artery
region.
MALS can be a problem in patients undergoing pan-
creaticoduodenectomy. When the gastroduodenal artery,
a main collateral pathway for the CA region from the
SMA in patients with MALS, is ligated during the proce-
dure, ischemia of the liver, stomach, and spleen may
result16–18). Therefore, the assessment of blood flow is
indispensable before pancreaticoduodenectomy in
patients with MALS. Our patient with MALS type B
required revascularization of the celiac axis during the
procedure because the blood flow to the CA region was
insufficient. Our findings may be useful for assessing
blood flow before pancreaticoduodenectomy.
Our study has some limitations. First, we did not
obtain conventional angiography and CT images on the
same day in all patients. However, celiac artery stenosis
in MALS patients does not change in the short term. Sec-
ond, not all patients with MALS type B had aneurysms.
To determine the incidence of PDA aneurysms, long-
term follow-up is needed. Third, we did not perform
ultrasonography because our study was retrospective.
Studies to identify differences on CT images and ultraso-
nograms are underway in our laboratory.
In conclusion, the maximum diameter of the PDA on
CTAs predicted the blood flow from the SMA to the CA
region in patients with MALS and may help predict the
risk for PDA aneurysm formation.
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